Sequoia Financial Advisors LLC Acquires 17,461 Shares of DENTSPLY SIRONA Inc. $XRAY

Sequoia Financial Advisors LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 159.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,408 shares of the medical instruments supplier’s stock after buying an additional 17,461 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in DENTSPLY SIRONA were worth $451,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in XRAY. AQR Capital Management LLC raised its holdings in DENTSPLY SIRONA by 119.4% in the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after buying an additional 3,453,662 shares during the last quarter. Goldman Sachs Group Inc. increased its position in DENTSPLY SIRONA by 827.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after purchasing an additional 2,172,343 shares during the period. Price T Rowe Associates Inc. MD increased its position in DENTSPLY SIRONA by 11.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock valued at $208,590,000 after purchasing an additional 1,412,517 shares during the period. Ninety One UK Ltd acquired a new stake in DENTSPLY SIRONA during the 2nd quarter valued at approximately $18,418,000. Finally, Edmond DE Rothschild Holding S.A. increased its position in DENTSPLY SIRONA by 26.4% during the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock valued at $43,526,000 after purchasing an additional 609,300 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $12.93 on Tuesday. The company has a market cap of $2.58 billion, a price-to-earnings ratio of -2.73, a price-to-earnings-growth ratio of 0.78 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 52 week low of $11.69 and a 52 week high of $24.86. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The firm has a 50 day moving average of $13.39 and a 200-day moving average of $14.52.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same quarter last year, the firm posted $0.49 EPS. The company’s quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -13.50%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on XRAY shares. Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, August 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Stifel Nicolaus decreased their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Finally, Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. Two analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $18.00.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.